Article Information
History
- September 8, 2021.
Article Versions
- Version 1 (September 2, 2021 - 07:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zita Hubler, PhD1,
- Xiao Song2,
- Cameron Norris2,
- Mehul Jani2,
- David Alouani, PhD2,
- Maureen Atchley2,
- Lisa Stempak, MD2,3,
- Sarah Cherian, MD2,3,
- Christine Schmotzer, MD2,3 and
- Navid Sadri, MD, PhD2,3,*
- 1Case Western Reserve University School of Medicine, Cleveland, OH, United States of America
- 2Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH
- 3Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH
- ↵*Correspondence
: Navid Sadri, M.D., Ph.D., University Hospitals Cleveland Medical Center, 7100 Euclid Avenue, Ste. 190, Cleveland, OH 44103, Email: navid.sadri{at}uhhospitals.org, Phone: 216-286-4286
Author contributorship: ZH, CS, and ZH designed the study. ZH and NS wrote the manuscript. ZH and NS analyzed the data. LS, SC, and CS oversaw the SAR2-CoV-2 testing and sample recruitment. CN, MA, and NS designed, validated and performed the wet bench of variant screening program and genomic sequencing. MJ, XS, and DA developed the informatic structure and algorithms for data capture and variant identification. XS and NS analyzed the SARS-CoV-2 genomic sequencing.